Mineralys Therapeutics Inc. trailing returns
How Mineralys Therapeutics Inc. (MLYS) has performed over the last day, week, month and year and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -6.2% | +0.0% | -6.2% | — |
| 5 days | -13.1% | +0.0% | -13.1% | -13.1%Oct 16 |
| 1 month | -26.3% | +0.0% | -26.3% | -31.0%Oct 16 |
| YTD | -44.1% | +0.0% | -44.1% | -44.1%Oct 16 |
| 1 year | -52.8% | +0.0% | -52.8% | -57.1%Oct 2026 |
| Since inception (2023) | +2.6% | +0.0% | +2.6%+10.1% | -68.9%Nov 2023 |
Growth of MLYS#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- Since inception (2023)+2.6%/year · +10.1%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in MLYS's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Mineralys Therapeutics Inc.'s return since inception?
- Since 2023, Mineralys Therapeutics Inc. (MLYS) has compounded at about +2.6% a year — +10.1% in total.